ArticleWorld journal of clinical cases2020

Significant benefits of pembrolizumab in treating refractory advanced pulmonary sarcomatoid carcinoma: A case report.

Ping Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.